On November 1, 2023, the U.S. Food and Drug Administration (FDA) approved VOQUEZNA® (vonoprazan) as a new treatment for the healing and maintenance of erosive esophagitis and the relief of heartburn associated with erosive esophagitis in adults. This FDA approval...
CD is a 50-year-old male presenting to your ambulatory care clinic to discuss vaping cessation. About three years ago, CD stopped smoking combustible tobacco cigarettes by transitioning to electronic cigarettes. Recently, he’s seen news articles about the unknown...
Is it safe for women to breastfeed while taking antidepressants? According to a CDC report from 2020, ~10.3% of women ages 18-39 take antidepressants, and the number of people diagnosed with depression and taking antidepressants continues to rise. In this article, we...
Depression is one of the top three health disorders in adults ages 18-34 with approximately 21.3% of these adults having depression. This means that many women suffer from depression during their peak childbearing years and will begin medication to treat it....
Restless Legs Syndrome (RLS) can be very debilitating for patients. It is a condition that often warrants pharmacotherapy. But which medications are most effective and how should we choose? I’ll lay out some of the most important RLS treatment clinical pearls in...
Trazodone belongs to a class of drugs called serotonin antagonist and reuptake inhibitors (SARIs). Although trazodone is only FDA-approved for the treatment of major depressive disorder (MDD), it is most often used off-label to manage insomnia. What’s interesting...
